Advancing delivery of RNA therapeutics with cationizable xenopeptides

Nucleic Acid Insights 2024; 1(9), 285–291

DOI: 10.18609/nai.2024.035

Published: 24 September
Interview
Ernst Wagner



In this interview Róisin McGuigan, Editor, Nucleic Acid Insights, speaks to Ernst Wagner, Chair of Pharmaceutical Biotechnology, Department of Pharmacy and Center of Nanoscience at LMU Munich, exploring advances in non-viral nucleic acid delivery systems and focusing on polycationic carriers and novel formulations including lipo-xenopeptides.